Blog - Page 554 of 5683 - QualityStocks

TuesdayFeb 06, 2024 1:57 pm

QualityStocksNewsBreaks – Correlate Energy Corp. (CIPI) Eyes Successful 2024 on Momentum and Achievements with Solar Projects

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is capitalizing on the continued corporate push for financially positive decentralized energy generation. “CIPI recently announced the successful commissioning of a major solar project located in American Tire Distributors’ (‘ATD’) Huntersville, North Carolina-based headquarters. This follows the successful commissioning of a solar project at Continental Envelope’s manufacturing plant in Geneva, Illinois, making it one of the state’s largest rooftop solar facilities. In the next two decades, the ATD solar power system installed will reduce CO2 emissions by as much as 5,463 tons, the…

TuesdayFeb 06, 2024 12:21 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces Participation at This Month’s BIO CEO & Investor Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, will be represented at the upcoming BIO CEO & Investor Conference. The conference is scheduled for Feb. 26–27, 2024, in New York City. According to the company, CFO Ryan Confer will present at the two-day event. His presentation, which will begin at 1:30 p.m. ET on Feb. 26, will include an overview of the company's gene therapies for cancer and diabetes; Confer will also be available for in-person, one-on-one meetings with investors through the conference platform. To view the full press release,…

TuesdayFeb 06, 2024 12:08 pm

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) CEO Discusses MS Trial Results During Latest Proactive Interview

Clene (NASDAQ: CLNN) CEO Rob Etherington was the featured guest on a recent Proactive interview. According to an announcement, Etherington joined Proactive host Steve Darling to discuss recent news the company has released regarding results from its long-term, open-label extension (“LTE”) of the VISIONARY-MS trial. Clene is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), Parkinson’s disease and multiple sclerosis (“MS”). Etherington and Darling discussed the trial, which involved gathering almost three years of research and information from participants with stable relapsing MS. Darling explained…

TuesdayFeb 06, 2024 9:45 am

Turbo Energy’s (NASDAQ: TURB) Sunbox Selected to Power Up Solar360’s Capabilities Aiming to Transform Spain’s Photovoltaic Landscape in 2024

Turbo Energy announces strategic partnership with Solar360, a joint venture between two Spanish heavyweights, Repsol and Telefónica España Turbo Energy will be the technology provider while Solar360 will be tasked with marketing energy services and installing Turbo Energy's smart batteries in residential, commercial, and industrial locations in Spain The companies are optimistic that this partnership will revolutionize the photovoltaic market in 2024, delivering substantial value to both parties and to consumers Turbo Energy (NASDAQ: TURB), a photovoltaic energy storage innovator, has started the new year on a high note with a strategic alliance announcement. The company has forged a collaboration…

TuesdayFeb 06, 2024 9:00 am

Clene Inc. (NASDAQ: CLNN) Reports ‘Unprecedented,’ Statistically Significant Long-Term Clinical Improvements for VISIONARY-MS Trial Participants with Stable Relapsing-Remitting MS

Clene recently reported new results from the open-label, long-term extension (“LTE”) of the VISIONARY-MS trial, involving participants with stable relapsing Multiple Sclerosis (“MS”) through week 144 (over 2.75 years) after the initial randomization Results from the 48-week double-blind period showed statistically significant improvements in vision (primary endpoint), as well as a combined improvement in cognition, walking speed, upper extremity function, and vision (secondary endpoint) with CNM-Au8 treatment, with further significant improvements in both vision and cognition extending throughout the 96-week LTE One of the trial’s key clinical advisors hailed the results as robust and consistent, describing the observed long-term clinical…

MondayFeb 05, 2024 12:58 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports on Production and Deliveries, Moves Forward with Production Line Installation

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is reporting “great strides” with the production and deliveries of its Class 1 and Class 3 commercial EVs. In addition, the company is reporting that its subsidiary, Mullen Advanced Energy LLC, "), is moving forward with the installation of its battery-pack production line at its new 122,000-square-foot, high-energy facility in Fullerton, California. The company announced the new facility in November 2023; the new facility is dedicated to producing next-generation, American-made EV battery components, modules and packs. “We are steadfastly focused on production, production, production,” said Mullen Automotive CEO and chair…

MondayFeb 05, 2024 12:39 pm

QualityStocksNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Phase2a Expansion of Acclaim-1 Clinical Study Enrolls, Doses First Patient

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has enrolled and dosed the first patient in the phase 2a expansion portion of its Acclaim-1 clinical study of Reqorsa(R) therapy (quaratusugene ozeplasmid). The study combines Genprex’s proprietary lead product candidate with AstraZeneca's Tagrisso(R) to treat patients with late-stage non-small cell lung cancer (“NSCLC”). An open-label, multicenter phase 1/2 clinical trial, the Accliam-1 trial has completed its phase 1 component and is moving on to phase 2. The company anticipates enrolling an estimated 66 patients in phase 2a, with one-half of the study participants…

MondayFeb 05, 2024 12:32 pm

QualityStocksNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Bringing Tried and Tested Solutions to Governments Worldwide

SuperCom Ltd. (NASDAQ: SPCB) is a leading global provider of traditional and digital identity solutions offering advanced safety, identification, and security products and solutions to governments. The company is proactively advancing its offender electronic monitoring solutions and services. “SuperCom offers government agencies a way to protect the victims of domestic abuse without the necessity of prolonged and expensive incarceration through advanced electronic monitoring. Since 1988, SuperCom has refined its offerings, yielding several offender monitoring solutions under its PureSecurity(TM) line, such as PureTrack(TM), PureCom(TM), PureTag(TM), PureProtect(TM), and PureBeacon(TM). These are in addition to its PureMonitor(TM) cloud-based software platform designed to deliver…

MondayFeb 05, 2024 12:27 pm

QualityStocksNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Inks Exclusive Agreement with Singapore-Based Distributor, Includes Evolve(TM) Soft Bait Orders

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has entered a distribution agreement with a leading Singapore-based pest-control product manufacturer and distributor: Agro Technic PTE Ltd. According to the announcement, the agreement includes a significant initial stocking order as well as annual minimums. The product range that SenesTech provides is a “perfect fit” for the Agro Technic business model, long-term strategy and market positioning, according to Agro Technic. The company is committed to offering market solutions that are both environmentally friendly but effective. “Agro Technic is a leading manufacturer and supplier for equipment and chemicals in Singapore,…

MondayFeb 05, 2024 12:12 pm

QualityStocksNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Upcoming Launch and Expansion of OPKO Health-Branded Storefront

NextPlat (NASDAQ: NXPL, NXPLW), a global e-Commerce provider, is preparing for the launch of its exclusive OPKO Health-branded storefront on Alibaba Group Holding Limited's ("Alibaba")(NYSE: BABA) Tmall Global in China. The move follows the company’s receipt of the initial set of approvals required to operate the store in the country. “We are pleased to reach this strategic milestone with our partners OPKO and Alibaba because we believe in the global potential of health and wellness as millions of consumers in China and around the globe continue to prioritize their wellbeing, contributing to the continued growth of this large and valuable…

Site Search

Company Search